OpenNashPodcasts

Person

Ahmed Elhusseiny

Ahmed Elhusseiny is a Roche executive and neuroscience PhD who spoke with Bernard Leong on Analyse Asia about Roche's work in Asia Pacific, how COVID-19 affected healthcare, and what personalised healthcare could mean. He is originally from Egypt and is also Canadian.

Elhusseiny told Leong that Roche has two parts, Pharmaceuticals and Diagnostics, and works in Asia across manufacturing, research, commercialization and medical services. He said COVID-19 disrupted almost every care pathway, including diabetes and cancer care. He described Asia's ageing population as a slowly creeping epidemic. He also said personalised healthcare would tailor treatment to a person's genetic profile and background.

1 episodes · 21 quoted claims

Roche is a Swiss company about 125 years old, according to Ahmed Elhusseiny, with a global footprint including Asia Pacific.

“This is a 125-year-old company. It's a Swiss company, but it's truly a global company with a global footprint, including, of course, in Asia Pacific.”

Analyse Asia with Bernard Leong · 0:05:23

Roche consists of two broad parts, Roche Pharmaceuticals and Roche Diagnostics, according to Ahmed Elhusseiny.

“Roche, broadly speaking, is also Roche Pharmaceuticals and Roche Diagnostics.”

Analyse Asia with Bernard Leong · 0:06:27

Ahmed Elhusseiny says Roche's presence in Asia spans manufacturing, research and development, commercialization and medical services.

“our presence extends from manufacturing to research and development and, of course, commercialization and medical services to patients all over the region.”

Analyse Asia with Bernard Leong · 0:06:27

Ahmed Elhusseiny says COVID-19 disrupted almost every care pathway, including diabetes and cancer care.

“it had also broader impact on the healthcare system as a whole. And this really impacted almost every care pathway that exists.”

Analyse Asia with Bernard Leong · 0:09:42

Ahmed Elhusseiny says regulatory approval pathways for healthcare products were accelerated because of COVID-19.

“even things like regulatory approval and the pathways by which products get reviewed. Those were absolutely accelerated because of COVID”

Analyse Asia with Bernard Leong · 0:10:37

Malaysia and Singapore used track and trace apps during the pandemic, according to Ahmed Elhusseiny.

“If you lived in Malaysia or in Singapore, of course, you had the track and trace apps.”

Analyse Asia with Bernard Leong · 0:11:51

Ahmed Elhusseiny says South Korea used other data sources, such as buying patterns, to track the pandemic.

“in Korea, they were also using other data sources to be able to track the pandemic. So buying patterns, for example.”

Analyse Asia with Bernard Leong · 0:11:51

Roche partnered with the World Health Organization to allocate one of its products fairly during the pandemic, according to Ahmed Elhusseiny.

“One example is a partnership we did with the WHO to allocate one of our products and to make sure that the allocation of this product is as fair and just as possible.”

Analyse Asia with Bernard Leong · 0:13:04

In Thailand, Roche partnered with local associations to provide COVID testing in remote areas using tuk-tuks.

“in Thailand, we partnered with local associations there to really be able to provide COVID testing in remote areas using tuk-tuks.”

Analyse Asia with Bernard Leong · 0:13:41

Malaysia's track and trace app, called MySejahtera in the show notes' context, was originally built for tracking and is being repurposed for health records.

“the track and trace app in Malaysia, which is called MySejHarta, it was initially, of course, developed to be able to to track, but now is being repurposed”

Analyse Asia with Bernard Leong · 0:17:49

The Malaysian app is being extended to record vaccination records and blood glucose levels, which could help diabetes care.

“including vaccination records and also blood glucose levels, which of course then can have potential”

Analyse Asia with Bernard Leong · 0:17:49

Ahmed Elhusseiny says teleconsultation technologies are being repurposed for telementoring and skills building for healthcare professionals in Asia.

“Those technologies are now being repurposed for things like telementoring and building skills and capabilities for healthcare professionals around Asia.”

Analyse Asia with Bernard Leong · 0:17:49

Ahmed Elhusseiny describes the ageing population in Asia Pacific as a slowly creeping epidemic bringing diseases such as Alzheimer's and cardiovascular disease.

“In the APAC region, the aging population is a slowly creeping pandemic or epidemic.”

Analyse Asia with Bernard Leong · 0:15:29

Ahmed Elhusseiny says personalised healthcare would tailor treatment to a person's genetic profile and background rather than giving everyone the same regimen.

“based on your genetic profile, based on your background, your healthcare, you would get something different based on that than I would.”

Analyse Asia with Bernard Leong · 0:22:46

Ahmed Elhusseiny says personalised healthcare combines medical science, digital technology and data science.

“Personalized healthcare brings together medical science, digital technology, and data science.”

Analyse Asia with Bernard Leong · 0:24:21

Ahmed Elhusseiny says personalised healthcare would be measurable partly through lower hospitalisation rates and shorter hospital stays.

“we could see people staying shorter periods in hospitals. So hospitalization rates would go down.”

Analyse Asia with Bernard Leong · 0:24:49

Ahmed Elhusseiny recommended the book In the Dragon's Shadow, about the interplay between China and the Asia-Pacific region.

“I'm actually reading a book called In the Dragon's Shadow, which actually is very topical for the region I'm in right now.”

Analyse Asia with Bernard Leong · 0:26:43